<<

THE ESC TEXTBOOK OF CARDIOVASCULAR 2nd edition

16 Spodick DH. Acute : current concepts and practice. Chapter 19 Pericardial JAMA 2003; 289: 1150–3. 17 Lange RA, Hillis LD. Clinical practice. . Jordi Soler-Soler and Jaume Sagristà-Sauleda N Engl J Med 2004; 351: 2195–002. 18 Troughton RW, Asher CR, Klein AL. Pericarditis. Lancet 2004; 363: 717–27. 19 Atar S, Chiu J, Forrester JS, et al . Bloody in patients with . Is the cause cancerous, References tuberculous, or iatrogenic in the 1990s? Chest 1999; 116: 1564–9. 1 Spodick DH. The . A Comprehensive Textbook, 20 Sagristá-Sauleda J, Barrabés JA, Permanyer-Miralda G, et al. 1997. New York: Marcel Dekker. Purulent pericarditis: a twenty-year experience in a General 2 Soler-Soler J, Permanyer-Miralda G, Sagristà-Sauleda J (eds.). Hospital. J Am Coll Cardiol 1993; 22 : 1661–5. Pericardial disease. New insights and old dilemmas, 1999. 21 Mercé J, Sagristá Sauleda J, Permanyer Miralda G, et al. Should Dordrecht: Kluwer Academic Publishers. pericardial drainage be performed routinely in patients who 3 Shabetai R. The Pericardium , 2003. Boston, MA: Kluwer have a large pericardial effusion without tamponade? Am J Med Academic Publishers. 1998; 105: 106–9. 4 Imazio M, Demichelis B, Cecchi E et al . Cardiac troponin I in 22 Maisch B, Bethge C, Drude L, et al . Pericardioscopy and acute pericarditis. J Am Coll Cardiol 2003; 42: 2144–8. epicardial biopsy. New diagnostic tools in pericardial and 5 Riera AR, Uchida AH, Schapachnik E et al (2008). Early perimyocardial disease. Eur J 1994; 15 (Suppl.C): 68–73. repolarization variant: epidemiological aspects, mechanism, 23 Nataf P, Cacoub P, Regan M, et al. Video-thoracoscopic and differential diagnosis. Cardiol J 2008; 15 : 4–16. pericardial window in the diagnosis and treatment of 6 Sagristà-Sauleda J, Mercé J, Permanyer-Miralda G, Soler-Soler pericardial effusions. Am J Cardiol 1998; 82 : 124–6. J. Clinical clues to the causes of large pericardial effusions. 24 Nugue O, Millaire A, Porte H, et al . Pericardioscopy in the Am J Med 2000; 109 : 95–101. etiologic diagnosis of pericardial effusion in 141 consecutive 7 Maisch B, Seferovic PM, Ristic AD, et al . Guidelines on the patients. Circulation 1996; 94: 1035–41. Diagnosis and Management of Pericardial Executive 25 Seferovic PM, Ristic AD, Maksimovic R, et al . Diagnostic value Summary: The Task Force on the Diagnosis and Management of pericardial biopsy: improvement with extensive sampling of Pericardial Diseases of the European Society of . enabled by pericardioscopy. Circulation 2003; 107: 978–83. Eur Heart J 2004; 25 : 587–610. 26 Imazio M, Demichellis B, Parrini I, et al. Day-hospital 8 Levy PY, Fournier PE, Charrel R, et al . Molecular analysis of treatment of acute pericarditis. A management program for pericardial fl uid: a 7-year experience. Eur Heart J 2006; 27: outpatient therapy. J Am Coll Cardiol 2004; 43 : 1042–6. 1942–6. 27 Imazio M, Bobbio M, Cecchi E, et al . Colchicine in addition 9 Permanyer-Miralda G, Sagristà-Sauleda J, Soler-Soler J. to conventional therapy for acute pericarditis. Results of the Primary acute pericardial disease: a prospective series of 231 COlchicine for acute PEricarditis (COPE) trial. Circulation consecutive patients. Am J Cardiol 1985; 56 : 623–30. 2005; 112: 2012–16. 10 Strang JI, Kakaza HH, Gibson DG, et al . Controlled trial 28 Soler-Soler J, Sagristà-Sauleda J, Permanyer-Miralda G. of as adjuvant in treatment of tuberculous Relapsing pericarditis. Heart 2004; 90: 1364–8. constrictive pericarditis in Transkei. Lancet 1987; 2: 1418–22. 29 Fowler NO, Harbin D. Recurrent acute pericarditis: Follow-up 11 Strang JIG, Kakaza HH, Gibson DG, et al . Controlled trial study of 31 patients. J Am Coll Cardiol 1986; 7: 300–5. of complete open surgical drainage and of prednisolone in 30 Rodriguez de la Serna A, Guindo J, Marti V, et al. Colchicine treatment of tuberculous pericardial effusion in Transkei. for recurrent pericarditis. Lancet 1987; 2: 1517. Lancet 1988; 2 : 759–63. 31 Guindo J, Rodriguez de la Serna A, Ramió J, et al. Recurrent 12 Hakim JG, Ternouth I, Mushangi E, et al. Double-blind pericarditis. Relief with colchicine. Circulation 1990; 82 : 1117–20. randomised placebo controlled trial of adjunctive prednisolone 32 Millaire A, de Groote P, Decoulx E, et al . Treatment of in the treatment of effusive in HIV recurrent pericarditis with colchicine. Eur Heart J 1994; 15 : seropositive patients. Heart 2000; 84 : 183–8. 120–4. 13 Soler-Soler J, Permanyer-Miralda G, Sagristà-Sauleda J. A 33 Adler Y, Finkelstein Y, Guindo J, et al . Colchicine treatment for systematic diagnostic approach to primary acute pericardial recurrent pericarditis. A decade of experience. Circulation 1998; disease: the Barcelona experience. Cardiol Clin 1990; 8 : 97(21): 2183–2185. 639–44. 34 Raatika M, Pelkonen PM, Karjalainen J, et al. Recurrent 14 Soler-Soler J, Permanyer-Miralda G, Sagristà-Sauleda J (eds.). pericarditis in children and adolescents. J Am Coll Cardiol 2003; Protocol for the diagnosis and management of pericardial 42: 759–64. diseases. Pericardial disease. New insights and old dilemmas, 35 Imazio M, Bobbio M, Cecchi E, et al . Colchicine as fi rst-choice 1990. Dordrecht: Kluwer Academic Publishers, pp.193–214. therapy for recurrent pericarditis: results of the CORE 15 Permanyer-Miralda G. Acute pericardial disease: approach to (COlchicine for REcurrent pericarditis) trial. Arch Intern Med the aetiologic diagnosis. Heart 2004; 90 : 252–4. 2005; 165: 1987–991.

© 2009 The European Society of Cardiology THE ESC TEXTBOOK OF CARDIOVASCULAR MEDICINE 2nd edition

36 Imazio M, Brucato A, Cumetti D, et al . Corticosteroids for 54 Hatle LK, Appleton CP, Popp RL. Differentiation of recurrent pericarditis: high versus low doses: a nonrandomized constrictive pericarditis and restrictive by observation. Circulation 2008; 118: 667–71. Doppler . Circulation 1989; 79 : 357–70. 37 Tuna IC, Danielson GK. Surgical management of pericardial 55 Palka P, Lange A, Donnelly JE, et al . Differentiation between diseases. Cardiol Clin 1990; 8 : 683–96. restrictive cardiomyopathy and constrictive pericarditis by early 38 Imazio M, Brucato A, Adler Y, et al . Prognosis of idiopathic diastolic Doppler myocardial velocity gradient at the posterior recurrent pericarditis as determined from previously published wall. Circulation 2000; 102 : 655–62. reports. Am J Cardiol 2007; 100 : 1026–8. 56 Talreja DR, Edwards WD, Danielson GK, et al. Constrictive 39 Reddy PS, Curtiss EI, Uretsky BF. Spectrum of hemodynamic pericarditis in 26 patients with histologically normal pericardial changes in cardiac tamponade. Am J Cardiol 1990; 66: 1487–91. thickness. Circulation 2003; 108: 1852–7. 40 Levine MJ, Lorell BH, Diver DJ, et al . Implications of 57 Seifert FC, Miller DC, Oesterle SN, et al . Surgical treatment of echocardiographically assisted diagnosis of pericardial constrictive pericarditis: analysis of outcome and diagnostic tamponade in contemporany medical patients: detection error. Circulation 1985; 72: 264–73. before hemodynamic embarrassment. J Am Coll Cardiol 58 Hancock EW. On the elastic and rigid forms of constrictive 1991; 17: 59–65. pericarditis. Am Heart J 1980; 100 : 917–23. 41 Mercé J, Sagristà-Sauleda J, Permanyer-Miralda G, et al. 59 Hancock EW. Subacute effusive-constrictive pericarditis. Correlation between clinical and Doppler echocardiographic Circulation 1971; 43: 183–92. fi ndings in patients with moderate and large pericardial 60 Sagristà-Sauleda J, Angel J, Sánchez A, et al. Effusive- effusion: Implications for the diagnosis of cardiac tamponade. constrictive pericarditis. N Engl J Med 2004; 350: 469–75. Am Heart J 1999; 138: 759–64. 61 Sagristà-Sauleda J, Permanyer-Miralda G, Candell-Riera J, et al. 42 Antman EM, Cargill V, Grossman W. Low-pressure cardiac Transient cardiac constriction: an unrecognized pattern of tamponade. Ann Intern Med 1979; 91: 403–6. evolution in effusive acute idiopathic pericarditis. Am J Cardiol 43 Sagristà-Sauleda J, Angel J, Sambola J, et al. Low-pressure 1987; 59 : 961–6. cardiac tamponade. Clinical and hemodynamic profi le. 62 Haley JH, Tajik AJ, Danielson GK, et al . Transient constrictive Circulation 2006; 114 : 945–52. pericarditis: causes and natural history. J Am Coll Cardiol 2004; 44 Sagristà-Sauleda J, Angel J, Sambola J, et al. Hemodynamic 43: 271–5. effects of volume expansion in patients with cardiac tamponade 63 Sagristà-Sauleda J, Permanyer-Miralda G, Soler-Soler J. Circulation 2008; 117: 1545–9. Tuberculous pericarditis: ten year experience with a prospective 45 Tsang TS, Enriquez-Sarano M, Freeman WK. Consecutive 1127 protocol for diagnosis and treatment. J Am Coll Cardiol 1988; therapeutic echocardiographically guided pericardiocenteses: 11: 724–8. clinical profi le, practice patterns, and outcomes spanning 64 Syed FF, Mayosi BM. A modern approach to tuberculous 21 years. Mayo Clin Proc 2002; 77 : 429–36. pericarditis. Prog Cardiovasc Dis 2007; 50: 218–36. 46 Savage DD, Garrison RJ, Brand F, et al . Prevalence and 65 Ntsekne M, Hakim J. Impact of human immunodefi ciency correlates of posterior extra echocardiographic spaces in a virus infection on cardiovascular disease in Africa. Circulation free-living population based-sample (the Framingham Study). 2005; 112 : 3602–7. Am J Cardiol 1983; 51 : 1207–12. 66 Long R, Younes M, Patton N, et al . Tuberculous pericarditis: 47 Soler-Soler J, Sagristà-Sauleda J, Permanyer-Miralda G. long-term outcome in patients who received medical therapy Aetiological diagnosis of pericardial disease: worthy efforts may alone. Am Heart J 1989; 117: 1133–9. not be applied in the appropriate direction. Eur Heart J 2006; 67 Trautner BW, Darouiche RO. Tuberculous pericarditis: 27: 1898–9. optimal diagnosis and management. Clin Infect Dis 2001; 33: 48 Sagristà-Sauleda J, Angel J, Permanyer-Miralda G, et al. 954–61. Long-term follow-up of idiopathic chronic pericardial effusion. 68 Mayosi BM, Ntsekhe M, Volmink JA, et al . Interventions for N Engl J Med 1999; 341: 2054–9. treating tuberculous pericarditis. Cochrane Database Syst Rev 49 Ling LH, Oh JK, Scahff HV, et al . Constrictive pericarditis 2002; 4 :CD00056. in the modern era: evolving clinical spectrum and impact 69 Tomkowski WZ, Gralec R, Kuca P, et al . Effectiveness of on outcome after pericardiectomy. Circulation 1999; 100: intrapericardial administration of streptokinase in purulent 1380–1386. pericarditis. Herz 2004; 29 : 802–5. 50 Gimlette TM. Constrictive pericarditis. Br Heart J 1959; 21: 9–16. 70 Galve E, Garcia-Del-Castillo H, Evangelista A, et al. Pericardial 51 Ling LH, Oh JK, Breen JF, et al. Calcifi c constrictive pericarditis: effusion in the course of : incidence, Is it still with us? Ann Intern Med 2000; 132 : 444–50. natural history, and clinical relevance. Circulation 1986; 73 : 52 Hancock EW. Differential diagnosis of restrictive 294–9. cardiomyopathy and constrictive pericarditis. Heart 2001; 86: 71 Correale E, Maggioni AP, Romano S, et al . Comparison of 343–9. frequency, diagnostic and prognostic signifi cance of pericardial 53 Candell-Riera J, Garcia-del-Castillo H, Permanyer-Miralda G, involvement in acute myocardial infarction treated with and et al . Echocardiographic features of the interventricular septum without thrombolytics. Gruppo Italiano per lo Studio della in chronic constrictive pericarditis. Circulation 1978; 57 : Sopravvivenza nell’Infarto Miocardico (GISSI). Am J Cardiol 1154–8. 1993; 71 : 1377–81.

© 2009 The European Society of Cardiology THE ESC TEXTBOOK OF CARDIOVASCULAR MEDICINE 2nd edition

72 Bendjelib K, Pugin J. Is dead? Chest 2004; 90 Miller RH, Horneffer PJ, Gardner TJ, et al . The epidemiology 126: 1680–2. of the postpericardiotomy syndrome: a common 73 Galve E, Permanyer-Miralda G, Tornos MP, et al. Self-limited of cardiac surgery. Am Heart J 1988; 116: 1323–19. acute pericarditis as initial manifestation of primary cardiac 91 Maisch B, Berg PA, Kochsiek K. Clinical signifi cance tumor. Am Heart J 1992; 123: 1690–2. of immunopathological fi ndings in patients with post- 74 Imazio M, Demichelis B, Parrini I, et al . Relation of acute pericardiotomy syndrome. I. Relevance of antibody pattern. pericardial disease to malignancy. Am J Cardiol 2005; 95 : 1393–4. Clin Exp Immunol 1979; 38 : 189–7. 75 Porte HL, Janecki-Delebecq TJ, Finzi L, et al. Pericardioscopy 92 Horneffer PJ, Miller RH, Pearson TA, et al . The effective for primary management of pericardial effusion in cancer treatment of postpericardiotomy syndrome after cardiac patients. Eur J Cardiothorac Surg 1999; 16 : 287–91. operations. A randomized placebo-controlled trial. J Thorac 76 Vaitkus PT, Herrmann HC, LeWinter MM. Treatment of Cardiovasc Surg 1990; 100 : 292–6. malignant pericardial effusion. JAMA 1994; 272: 59–64. 93 Finkelstein Y, Shemesh J, Mahlab K, et al . Colchicine for the 77 Gunukula SR, Spodick D. Pericardial disease in renal patients. prevention of postpericardiotomy syndrome. Herz 2002; 27: Semin Nephrol 2001; 21 : 52–6. 791–4. 78 Rutsky EA, Rostand SG. Treatment of uremic pericarditis and 94 Kabadi UM, Kumar SP. Pericardial effusion in primary pericardial effusion. Am J Kidney Dis 1987; 10: 2–8. hypothyroidism. Am Heart J 1990; 120: 1393–5. 79 Spaia S, Patsalas S, Agelou A, et al . Managing refractory 95 Gaya AM, Ashford RF. Cardiac complications of radiation uraemic pericarditis with colchicine. Nephrol Dial Transplant therapy. Clin Oncol (R Coll Radiol) 2005; 17: 153–9. 2004; 19: 2422–33. 96 Risti´c AD, Seferovi´c PM, Ljubi´c A, et al . Pericardial disease in 80 Heidenreich PA, Eisenberg MJ, Kee LL, et al. Pericardial effusion . Herz 2003; 28: 209–15. in AIDS. Incidence and survival. Circulation 1995; 92: 3229–34. 97 Dib C, Tajik AJ, Park S, et al . Chylopericardium in adults: a 81 Khunnawat C, Mukerji S, Havlichek D Jr, et al. Cardiovascular literature review over the past decade (1996–2006). J Thorac manifestations in human immunodefi ciency virus-infected Cardiovasc Surg 2008; 136 : 650–6. patients. Am J Cardiol 2008; 102: 635–42. 98 Campbell RM, Benson LN, Williams WW, et al. 82 Barbaro G. Cardiovascular manifestations of HIV infection. Chylopericardium after cardiac operations in children. Ann Circulation 2002; 106: 1420–5. Thorac Surg 2001; 72: 193–6. 83 Knockaert DC. Cardiac involvement in systemic infl ammatory 99 Rabinovici R, Szewczyk D, Ovadia P, et al. Candida diseases. Eur Heart J 2007; 28: 1797–1804. pericarditis: clinical profi le and treatment. Ann Thorac Surg 84 Moder KG, Miller TD, Tazelaar HD. Cardiac involvement in 1997; 63 : 1200–4. systemic erythematosus. Mayo Clin Proc 1999; 74 : 275–84. 100 Spodick DH. Drug and toxin-related pericardial disease. 85 Byers RJ, Marshall DAS, Freemonta AJ. Pericardial involvement In Spodick DH (ed.) The Pericardium. A Comprehensive in systemic sclerosis. Ann Rheum Dis 1997; 56 : 393–4. Textbook , 1997. New York: Marcel Dekker, pp. 411–16. 86 Corrao S, Sallì L, Arnone S, et al . Cardiac involvement in 101 Luk A, Ahn E, Vaideeswar P, Butany JW. Pericardial tumors. rheumatoid : evidence of silent heart disease. Eur Heart Semin Diagn Pathol 2008; 25: 47–53. J 1995; 16: 253–6. 102 Thomason R, Schlegel W, Lucca M, et al . Primary malignant 87 Maisch B, Risti´c AD, Pankuweit S. Intrapericardial treatment of mesothelioma of the pericardium. Case report and literature autoreactive pericardial effusion with triamcinolone; the way to review. Tex Heart Inst J 1994; 21: 170–4. avoid side effects of systemic corticosteroid therapy. Eur Heart J 103 Gatzoulis MA, Munk MD, Merchant N, et al. Isolated 2002; 23: 1503–8. congenital absence of the pericardium: clinical presentation, 88 Shabetai R. Recurrent pericarditis: recent advances and diagnosis, and management. Ann Thorac Surg 2000; 69: remaining questions. Circulation 2005; 112 : 1921–3. 1209–15. 89 LeWinter MM. Pericardial diseases. In Libby P, Bonow RO, 104 Abbas AE, Appleton CP, Liu PT, et al . Congenital absence Mann DL, et al . (eds.) Braunwald’s Heart Disease. A Textbook of the pericardium: case presentation and review of literature. of Cardiovascular Medicine, 8 th edn., 2008. Philadelphia, PA: Int J Cardiol 2005; 98: 21–5. Saunders, pp.1829–53.

© 2009 The European Society of Cardiology